Skip to main content
. 2018 Mar 26;75(7):876–880. doi: 10.1001/jamaneurol.2018.0809

Table 1. Baseline Characteristics.

Characteristic No. (%)
Smartphone Users
(n = 250)
Development Cohort
(n = 129)
Clinic Cohort With Parkinson Disease
(n = 23)
Clinic Cohort Without Parkinson Disease
(n = 17)
Demographic
Age, y, mean (SD) 57.2 (9.4) 58.7 (8.6) 64.6 (11.5) 54.2 (16.5)
Women 95 (38.0) 55 (42.6) 11 (48) 12 (71)
White race 225 (90.0) 123 (95.3) 22 (96) 16 (94)
Hispanic/Latino 15 (6.0) 9 (7.0) 0 (0) 0 (0)
College graduate 238 (95.2) 121 (93.7) 14 (61) 8 (47)
Using internet or email at home 250 (100) 129 (100) 21 (91) 17 (100)
Clinical
Time since diagnosis, y, mean (SD) 4.4 (4.9) 4.3 (4.4) 7.0 (4.1) N/A
Taking levodopa 96 97 90 N/A
MDS-UPDRS total score, mean (SD) NA NA 55.0 (26.5) 4.6 (4.6)
MDS-UPDRS III score, mean (SD) NA NA 26.9 (11.2) 1.2 (1.7)
Timed Up and Go Test, s, mean (SD) NA NA 11.2 (3.3) 8.1 (1.3)
Hoehn and Yahr score, stage, mean (SD) NA NA 2.1 (0.7) 0.0 (0.0)

Abbreviations: MDS-UPDRS, Movement Disorder Society Unified Parkinson Disease’s Rating Scale; NA, not applicable.